CYP2C9 c.1003C>T

CYP2C9 c.1003C>T

The CYP2C9 c.1003C>T Novallele Genotyping Assay identifies a single mutation associated with the CYP2C9*11 allele. The CYP2C9*11 allele may cause reduced warfarin metabolism. Inhibited warfarin metabolism is characterized by bleeding tendency and thromboembolic diseases, such as pulmonary embolism and stroke.


Get in touch

Get in touch with the team

  • :

Product Description

The CYP2C9 c.1003C>T Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.